UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

A prospective randomised phase-II trial with gemcitabine versus gemcitabine plus sunitinib in advanced pancreatic cancer

European journal of cancer (1990), 2015-01, Vol.51 (1), p.27-36

2015

Volltextzugriff (PDF)

A prospective randomised phase-II trial with gemcitabine versus gemcitabine plus sunitinib in advanced pancreatic cancer: a study of the CESAR Central European Society for Anticancer Drug Research-EWIV

European journal of cancer (1990), 2015-01, Vol.51 (1), p.27

2015

Volltextzugriff (PDF)

Elevated preoperative CEA is associated with worse survival in stage I–III rectal cancer patients

British journal of cancer, 2012-07, Vol.107 (2), p.266-274

2012

Volltextzugriff (PDF)

Gender-specific elimination of continuous-infusional 5-fluorouracil in patients with gastrointestinal malignancies: results from a prospective population pharmacokinetic study

Cancer chemotherapy and pharmacology, 2013-02, Vol.71 (2), p.361-370

2013

Volltextzugriff (PDF)

Clinical benefit of fulvestrant in postmenopausal women with advanced breast cancer and primary or acquired resistance to aromatase inhibitors: final results of phase II Swiss Group for Clinical Cancer Research Trial (SAKK 21/00)

Annals of oncology, 2007-01, Vol.18 (1), p.64-69

2007

Volltextzugriff (PDF)

Multicenter phase II trial of preoperative induction chemotherapy followed by chemoradiation with docetaxel and cisplatin for locally advanced esophageal carcinoma (SAKK 75/02)

Annals of oncology, 2009-09, Vol.20 (9), p.1522-1528

2009

Volltextzugriff (PDF)

Procollagen type I N-propeptide is a predictor of skeletal morbidity in patients with malignant osteolytic bone disease on bisphosphonates

Cancer chemotherapy and pharmacology, 2011-05, Vol.67 (5), p.1137-1144

2011

Volltextzugriff (PDF)

EE374 Estimating the Impact of Tumors of the Oesophageal and Gastro-Oesophageal Junction on Work, Leisure and Household Activity Times: Evidence from a Patient Survey in Switzerland

Value in health, 2023-12, Vol.26 (12), p.S123

2023

Volltextzugriff (PDF)

Capecitabine and Vinorelbine as First-Line Treatment in Elderly Patients (≥65 Years) with Metastatic Breast Cancer : A Phase II Trial (SAKK 25/99)

Oncology, 2007-01, Vol.73 (3-4), p.228-237

2007

Volltextzugriff (PDF)

573PRELEVANT UPSTAGING OF PN2 CM0 COLORECTAL CANCER PATIENTS WITH POST-SURGERY 18F-FDG PET-CT

Annals of oncology, 2014-09, Vol.25 (suppl_4), p.iv196-iv197

2014

Volltextzugriff (PDF)

Relevant Upstaging of Pn2 Cm0 Colorectal Cancer Patients with Post-Surgery 18F-Fdg Pet-Ct

Annals of oncology, 2014-09, Vol.25, p.iv196

2014

Volltextzugriff (PDF)

3029 POSTER A Swiss multicentre phase II study of capecitabine plus oxaliplatin (CAPOX) in combination with preoperative pelvic radiotherapy in patients (pts) with locally advanced rectal cancer

European journal of cancer supplements, 2007, Vol.5 (4), p.244-244

2007

Volltextzugriff (PDF)

Heated oxaliplatin infusion (37°C) in combination with capecitabine for metastatic colorectal cancer: Can it reduce oxaliplatin-associated neuropathy?

Journal of clinical oncology, 2008-05, Vol.26 (15_suppl), p.20660-20660

2008

Volltextzugriff (PDF)

Capecitabine and Vinorelbine as First-Line Treatment in Elderly Patients: A Phase II Trial (SAKK 25/99)

Oncology, 2008-04, Vol.73 (3-4), p.228

2008

Volltextzugriff (PDF)

Phase II study of Sorafenib (BAY 43–9006) in hormone-refractory patients with prostate cancer: A study of the Central European Society for Anticancer Drug Research—EWIV (CESAR)

Journal of clinical oncology, 2006-06, Vol.24 (18_suppl), p.3094-3094

2006

Volltextzugriff (PDF)

Anastrozole ('Arimidex') versus tamoxifen as first-line therapy in postmenopausal women with advanced breast cancer: results of the double-blind cross-over SAKK trial 21/95 - a sub-study of the TARGET (Tamoxifen or 'Arimidex' Randomized Group efficacy and tolerability) trial

Breast cancer research and treatment, 2004-06, Vol.85 (3), p.247-254

2004

Volltextzugriff (PDF)

Capecitabine and Vinorelbine as First-Line Treatment in Elderly Patients (≥65 Years) with Metastatic Breast Cancer

Oncology, 2007-12, Vol.73 (3-4), p.228-237

2007

Volltextzugriff (PDF)

Anastrozole: pharmacological and clinical profile in postmenopausal women with breast cancer

Expert review of anticancer therapy, 2001-08, Vol.1 (2), p.169-176

2001

Volltextzugriff (PDF)

Repeated double-blind pamidronate 60 versus 90 Mg in malignant osteolytic disease and pain: Preliminary results

Bone (New York, N.Y.), 1995-12, Vol.17 (6), p.614

1995

Volltextzugriff (PDF)

Adjuvant endocrine therapy in postmenopausal breast cancer patients

Breast (Edinburgh), 2005-12, Vol.14 (6), p.446-451

2005

Volltextzugriff (PDF)

True synergism between verapamil and quinine in reversing P-glycoprotein associated multidrug resistance: 73

Anti-cancer drugs, 1994-09, Vol.5, p.32

1994

Volltextzugriff (PDF)

Effects of prolonged drug exposure on P-glycoprotein-associated resistance widely differ for various cytotoxic agents: 94

Anti-cancer drugs, 1994-09, Vol.5, p.41

1994

Volltextzugriff (PDF)

True synergism between verapamil and quinine in reversing P-glycoprotein associated multidrug resistance: 73

Anti-cancer drugs, 1994-09, Vol.5 Suppl 1, p.32-32

1994

Volltextzugriff (PDF)

Effects of prolonged drug exposure on P-glycoprotein-associated resistance widely differ for various cytotoxic agents: 94

Anti-cancer drugs, 1994-09, Vol.5 Suppl 1, p.41-41

1994

Volltextzugriff (PDF)

1 – 25 von 91

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(79)
Mit Volltextzugriff
(73)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

A prospective randomised phase-II trial with gemcitabine versus gemcitabine plus sunitinib in advanced pancreatic cancer

A prospective randomised phase-II trial with gemcitabine versus gemcitabine plus sunitinib in advanced pancreatic cancer: a study of the CESAR Central European Society for Anticancer Drug Research-EWIV

Elevated preoperative CEA is associated with worse survival in stage I–III rectal cancer patients

Gender-specific elimination of continuous-infusional 5-fluorouracil in patients with gastrointestinal malignancies: results from a prospective population pharmacokinetic study

Clinical benefit of fulvestrant in postmenopausal women with advanced breast cancer and primary or acquired resistance to aromatase inhibitors: final results of phase II Swiss Group for Clinical Cancer Research Trial (SAKK 21/00)

Multicenter phase II trial of preoperative induction chemotherapy followed by chemoradiation with docetaxel and cisplatin for locally advanced esophageal carcinoma (SAKK 75/02)

Procollagen type I N-propeptide is a predictor of skeletal morbidity in patients with malignant osteolytic bone disease on bisphosphonates

EE374 Estimating the Impact of Tumors of the Oesophageal and Gastro-Oesophageal Junction on Work, Leisure and Household Activity Times: Evidence from a Patient Survey in Switzerland

Capecitabine and Vinorelbine as First-Line Treatment in Elderly Patients (≥65 Years) with Metastatic Breast Cancer : A Phase II Trial (SAKK 25/99)

573PRELEVANT UPSTAGING OF PN2 CM0 COLORECTAL CANCER PATIENTS WITH POST-SURGERY 18F-FDG PET-CT

Relevant Upstaging of Pn2 Cm0 Colorectal Cancer Patients with Post-Surgery 18F-Fdg Pet-Ct

3029 POSTER A Swiss multicentre phase II study of capecitabine plus oxaliplatin (CAPOX) in combination with preoperative pelvic radiotherapy in patients (pts) with locally advanced rectal cancer

Heated oxaliplatin infusion (37°C) in combination with capecitabine for metastatic colorectal cancer: Can it reduce oxaliplatin-associated neuropathy?

Short regimen of rituximab plus lenalidomide in follicular lymphoma patients in need of first-line therapy

Capecitabine and Vinorelbine as First-Line Treatment in Elderly Patients: A Phase II Trial (SAKK 25/99)

Phase II study of Sorafenib (BAY 43–9006) in hormone-refractory patients with prostate cancer: A study of the Central European Society for Anticancer Drug Research—EWIV (CESAR)

Anastrozole ('Arimidex') versus tamoxifen as first-line therapy in postmenopausal women with advanced breast cancer: results of the double-blind cross-over SAKK trial 21/95 - a sub-study of the TARGET (Tamoxifen or 'Arimidex' Randomized Group efficacy and tolerability) trial

Capecitabine and Vinorelbine as First-Line Treatment in Elderly Patients (≥65 Years) with Metastatic Breast Cancer

Anastrozole: pharmacological and clinical profile in postmenopausal women with breast cancer

Repeated double-blind pamidronate 60 versus 90 Mg in malignant osteolytic disease and pain: Preliminary results

Adjuvant endocrine therapy in postmenopausal breast cancer patients

True synergism between verapamil and quinine in reversing P-glycoprotein associated multidrug resistance: 73

Effects of prolonged drug exposure on P-glycoprotein-associated resistance widely differ for various cytotoxic agents: 94

True synergism between verapamil and quinine in reversing P-glycoprotein associated multidrug resistance: 73

Effects of prolonged drug exposure on P-glycoprotein-associated resistance widely differ for various cytotoxic agents: 94

Suchergebnisse filtern